Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Vinorelbine is a cycle-specific drug, which is often used in the treatment of non-small cell lung cancer (NSCLC), breast cancer, ovarian cancer, head and neck phosphorous cancer, and leukemia, and also has a strong inhibitory effect on small cell lung cancer, colon cancer, brain tumor, malignant melanoma, etc.